The suppression of PRR5L expression has been suggested to promote tumor necrosis factor alpha (TNFα)-associated autoimmune diseases, such as asthma, rheumatoid arthritis, psoriasis, and inflammatory bowel disease at adulthood [162]. Here, TNF is linked to autoimmune disease.